| Glioblastoma, IDH-Wildtype studied in …STUDIED_INderived200 of 303show all (up to 200) |
|---|
| → studied in | NCT05864534Phase 2 · active not recruiting Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432804Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896568Phase 1 · recruiting MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174197Phase 1/Phase 2 · completed Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708961Phase 2 · suspended Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07089641Phase 1 · recruiting ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03115333NA · active not recruiting DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698524Phase 1 · recruiting A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Supratentorial Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349693Phase 2/Phase 3 · not yet recruiting Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07452458Phase 3 · recruiting Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06410248Phase 1 · recruiting Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06934889Phase 1 · recruiting Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991870Phase 1 · recruiting Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337686Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145115Phase 2 · active not recruiting A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236036Phase 1 · active not recruiting Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778602early Phase 1 · not yet recruiting Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039281Phase 1/Phase 2 · active not recruiting Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319027Phase 2 · recruiting Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095376Phase 3 · active not recruiting Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07091864NA · recruiting Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186401Phase 1 · recruiting Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06614855Phase 1 · active not recruiting A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544992Phase 1 · recruiting Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197934Phase 1 · active not recruiting WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07754734Phase 2 · not yet recruiting STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02455557Phase 2 · active not recruiting SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01837862Phase 1/Phase 2 · active not recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152982Phase 2/Phase 3 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739017Phase 1 · not yet recruiting OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04555577Phase 1 · active not recruiting Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991101Phase 2 · recruiting Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879250Phase 2 · recruiting WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03423628Phase 1 · active not recruiting A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer · condition mapped ALIAS · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07712770early Phase 1 · not yet recruiting Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07468136Phase 1/Phase 2 · recruiting Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07655869early Phase 1 · recruiting [177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07648823early Phase 1 · recruiting Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07422363Phase 1 · not yet recruiting Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05218408Phase 1/Phase 2 · withdrawn CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223034Phase 1 · recruiting A Study of 177Lu-PSMA-617 in People With Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06806228Phase 1 · suspended Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620548Phase 2 · not yet recruiting Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05271240Phase 3 · recruiting Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05736406Phase 1/Phase 2 · active not recruiting A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma · condition mapped ALIAS · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04477200Phase 1 · active not recruiting Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192359Phase 1 · active not recruiting Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05091866early Phase 1 · terminated Natural Progesterone for the Treatment of Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06649851Phase 2 · recruiting G-CSF After Chemo-radiation in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04396860Phase 2/Phase 3 · completed Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04817254Phase 2 · completed Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04528680Phase 1/Phase 2 · active not recruiting Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06419946Phase 3 · recruiting Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07134842Phase 1 · recruiting A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment. · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07301268Phase 2 · recruiting GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05789394Phase 1 · recruiting Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504381Phase 1/Phase 2 · recruiting DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942264Phase 1/Phase 2 · terminated Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318818Phase 1/Phase 2 · recruiting A Clinical Trial of P134 Cells in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04482933Phase 2 · withdrawn HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05756985recruiting Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216329Phase 1 · active not recruiting Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05084430Phase 1/Phase 2 · recruiting Study of Pembrolizumab and M032 (NSC 733972) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347210Phase 2 · not yet recruiting Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma · condition mapped ALIAS · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05465954Phase 2 · recruiting Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095375Phase 1 · completed Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02709226Phase 1 · completed Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06359379Phase 2 · terminated Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04945148Phase 2 · recruiting Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04250922Phase 2/Phase 3 · active not recruiting LAM561 With RT and TMZ for Adults With Glioblastoma · condition mapped ALIAS · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03746080Phase 2 · completed Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma with Primitive Neuronal Component | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03107780Phase 1 · terminated Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06455605Phase 1 · recruiting D2C7-IT + 2141-V11 Combination Post-resection in rGBM · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734560Phase 1/Phase 2 · recruiting D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165632early Phase 1 · completed Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01931098Phase 2 · completed Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03137888Phase 2 · completed Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05929495Phase 2 · recruiting Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05909618Phase 2 · recruiting Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05375318completed BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879367Phase 1 · recruiting Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03452930Phase 1 · completed Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01430351Phase 1 · terminated Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186509Phase 1 · completed Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05759195NA · completed Biomolecular Analysis for Predicting Response to Regorafenib · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941234NA · recruiting Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01903330Phase 2 · unknown ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01894061Phase 2 · completed NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01814813Phase 2 · terminated Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04397679Phase 1 · terminated Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06328036Phase 2 · withdrawn Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101905Phase 1 · completed Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03973918Phase 2 · terminated Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00102648Phase 1 · active not recruiting Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149850Phase 2 · completed Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03250299Phase 1 · terminated Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06418113Phase 1 · recruiting Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05318612Phase 3 · active not recruiting Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT) · condition mapped ALIAS · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043391Phase 1 · completed Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02133183Phase 1 · terminated Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02052648Phase 1/Phase 2 · completed Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06327451Phase 2 · recruiting Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06283927recruiting The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06118723recruiting The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06273176recruiting The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01922076Phase 1 · completed Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06160596recruiting Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146725recruiting The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146738recruiting The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168270Phase 1 · terminated Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03027388Phase 2 · completed Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01957956early Phase 1 · completed Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02658981Phase 1 · completed Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02386826Phase 1 · completed INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360708early Phase 1 · completed Vaccine Therapy in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661282Phase 1/Phase 2 · completed Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366728Phase 2 · completed DC Migration Study for Newly-Diagnosed GBM · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00662506Phase 1/Phase 2 · completed Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01721577Phase 1/Phase 2 · terminated Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02573324Phase 3 · completed A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860376completed Ex Vivo Drug Sensitivity Testing and Mutation Profiling · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05842746Phase 2 · not yet recruiting Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04091503Phase 1 · completed Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05326334recruiting THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05100641Phase 3 · not yet recruiting AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM · condition mapped ALIAS · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02664363Phase 1 · terminated EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100802Phase 2 · completed Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694416Phase 2 · unknown Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657315Phase 1/Phase 2 · completed Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311920Phase 1 · completed Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730950Phase 2 · completed Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822275Phase 2 · terminated Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05017610early Phase 1 · withdrawn Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020017early Phase 1 · completed NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04489420Phase 1 · terminated Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04926168withdrawn 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00731731Phase 1/Phase 2 · completed Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01062425Phase 2 · completed Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01609790Phase 2 · completed Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367715Phase 2 · completed Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669669Phase 1/Phase 2 · terminated O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641326Phase 2 · terminated Sunitinib in Sarcomas of the Central Nervous System · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004874Phase 2 · completed Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01856933Phase 2 · completed BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01189266Phase 1/Phase 2 · completed Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02015819Phase 1 · completed Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05033587Phase 2 · unknown Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020602Phase 1 · completed BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00879437Phase 2 · completed Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01051557Phase 1/Phase 2 · completed Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02798406Phase 2 · completed Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02743078Phase 2 · terminated Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04854044Phase 1 · withdrawn ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03283631Phase 1 · terminated Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02255461Phase 1 · terminated Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors · condition mapped CURATED_BROADER · 303 trials mapped (84 active) | — | — | Childhood Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01740258Phase 2 · completed Bevacizumab Beyond Progression (BBP) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04725214Phase 2 · unknown Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031083Phase 1 · completed Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052208Phase 1/Phase 2 · completed Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00402116Phase 1/Phase 2 · completed Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03014804Phase 2 · withdrawn Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943462withdrawn Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502708Phase 1 · completed Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165671NA · completed Carbon Ion Radiotherapy for Primary Glioblastoma · condition mapped ALIAS · 303 trials mapped (84 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01478321Phase 2 · terminated Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498328Phase 2 · completed A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Small Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04224441Phase 2 · unknown Repurposing Chlorpromazine in the Treatment of Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843814NA · terminated Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00035373terminated Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01454596Phase 1/Phase 2 · completed CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01514201Phase 1/Phase 2 · completed Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423735Phase 2 · completed Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884741Phase 3 · completed Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337426Phase 1 · completed Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00902577Phase 2 · completed MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00441142Phase 1/Phase 2 · completed Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186406Phase 2 · terminated Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00734526Phase 1 · terminated Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01977677Phase 1/Phase 2 · completed Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00329719Phase 1/Phase 2 · completed Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433381Phase 2 · completed Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01103375Phase 1 · terminated Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01575275Phase 2 · terminated Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01836549Phase 2 · terminated Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03275558Phase 1 · withdrawn Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107003Phase 2 · completed GW572016 to Treat Recurrent Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01086345early Phase 1 · terminated Radiosurgery Plus Bevacizumab in Glioblastoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234805NA · terminated Yoga Therapy in Treating Patients With Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335764Phase 1/Phase 2 · completed Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01648348Phase 1/Phase 2 · completed Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 303 trials mapped (84 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |